Skip to main content

Advertisement

SpringerLink
Log in

Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

Surgical cytoreduction of peritoneal surface malignancy of colorectal origin in combination with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) has become an established treatment approach. Only a few of animal models for scientific research on various therapeutic strategies have been described yet. The feasibility of an established rat model with a peritoneal surface malignancy from colorectal origin for treatment investigation should be examined in this study.

Methods

Peritoneal surface malignancy of colonic origin was induced in 90 male BD IX rats. Animals were randomised into six groups (15 animals per one control and five treatment groups). One treatment group underwent only surgical debulking. The animals of the other four treatment groups received additional interventions: hyperthermic intraperitoneal chemotherapy with mitomycin or gemcitabine, photodynamic therapy or taurolidine lavage. Twenty-one days after treatment, the intraperitoneal status was investigated. Tumour weight, count of tumour nodules and experimental Peritoneal Carcinosis Index (ePCI) were detected.

Results

Extended surgical cytoreduction and additional treatments including HIPEC were feasible in this rat model. All treatment groups had a significant lower tumour weight, account of tumour nodes and ePCI if compared with the control group. Comparing the additional therapies only HIPEC with mitomycin lead to relevant tumour reduction after surgery.

Conclusion

This rat model is suitable for research on the multimodal treatment of peritoneal malignancies. A persisting cytoreductive effect of surgical tumour debulking could be proven. Only additional HIPEC therapy with mitomycin showed a significant tumour reduction. This animal model provides the opportunity to investigate different therapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358–363

    Article  CAS  PubMed  Google Scholar 

  2. Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA et al (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–3292

    Article  CAS  PubMed  Google Scholar 

  3. Sugarbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124–132

    CAS  PubMed  Google Scholar 

  4. Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29–42

    Article  CAS  PubMed  Google Scholar 

  5. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H et al (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–3743

    Article  PubMed  Google Scholar 

  6. Aarts F, Hendriks T, Boerman OC, Koppe MJ, Oyen WJ, Bleichrodt RP (2007) A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. Ann Surg Oncol 14:3274–3282

    Article  CAS  PubMed  Google Scholar 

  7. Aarts F, Bleichrodt RP, de MB, Lomme R, Boerman OC, Hendriks T (2008) The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat. Ann Surg Oncol 15:3299–3307

    Article  CAS  PubMed  Google Scholar 

  8. Monneuse O, Mestrallet JP, Quash G, Gilly FN, Glehen O (2005) Intraperitoneal treatment with dimethylthioampal (DIMATE) combined with surgical debulking is effective for experimental peritoneal carcinomatosis in a rat model23. J Gastrointest Surg 9:769–774

    Article  PubMed  Google Scholar 

  9. Barlogie B, Corry PM, Drewinko B (1980) In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Res 40:1165–1168

    CAS  PubMed  Google Scholar 

  10. van Ruth S, Verwaal VJ, Zoetmulder FA (2003) Pharmacokinetics of intraperitoneal mitomycin C. Surg Oncol Clin N Am 12:771–780

    Article  PubMed  Google Scholar 

  11. Pestieau SR, Stuart OA, Chang D, Jacquet P, Sugarbaker PH (1998) Pharmacokinetics of intraperitoneal gemcitabine in a rat model. Tumori 84:706–711

    CAS  PubMed  Google Scholar 

  12. Ridwelski K, Meyer F, Hribaschek A, Kasper U, Lippert H (2002) Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurrence of peritoneal carcinomatosis. J Surg Oncol 79:10–16

    Article  CAS  PubMed  Google Scholar 

  13. Braumann C, Ordemann J, Kilian M, Wenger FA, Jacobi CA (2003) Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy. Clin Exp Metastasis 20:387–394

    Article  CAS  PubMed  Google Scholar 

  14. Jacobi CA, Menenakos C, Braumann C (2005) Taurolidine—a new drug with anti-tumor and anti-angiogenic effects. Anticancer Drugs 16:917–921

    Article  CAS  PubMed  Google Scholar 

  15. Veenhuizen RB, Marijnissen JP, Kenemans P, Ruevekamp-Helmers MC, ‘t Mannetje LW et al (1996) Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma. Br J Cancer 73:1387–1392

    CAS  PubMed  Google Scholar 

  16. Ismail M, Henklein P, Huang X, Braumann C, Ruckert RI, Dubiel W (2006) Identification of HIV-1 Tat peptides for future therapeutic angiogenesis. Eur J Haematol 77:157–165

    Article  CAS  PubMed  Google Scholar 

  17. Steller EP, Ottow RT, Matthews W, Sugarbaker PH, Rosenberg SA (1985) Recombinant interleukin-2 and adoptively transferred lymphokine activated killer cells in the treatment of experimental peritoneal carcinomatosis. Surg Forum 36:390–392

    Google Scholar 

  18. Pelz JO, Doerfer J, Hohenberger W, Meyer T (2005) A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis. BMC Cancer 5:56

    Article  PubMed  CAS  Google Scholar 

  19. Ordemann J, Hoflich C, Braumann C, Hartmann J, Jacobi CA (2005) Impact of pneumoperitoneum on expression of E-cadherin, CD44v6 and CD54 (ICAM-1) on HT-29 colon-carcinoma cells. Zentralbl Chir 130:405–409

    Article  CAS  PubMed  Google Scholar 

  20. Jacobi CA, Ordemann J, Zieren HU, Muller JM (1998) Effect of intra-abdominal pressure in laparoscopy on intraperitoneal tumor growth and development of trocar metastases. An animal experiment study in the rat model. Langenbecks Arch Chir Suppl Kongressbd 115:529–533

    CAS  PubMed  Google Scholar 

  21. Hartmann J, Kilian M, Atanassov V, Braumann C, Ordemann J, Jacobi CA (2008) First surgical tumour reduction of peritoneal surface malignancy in a rat’s model. Clin Exp Metastasis 25:445–449

    Article  PubMed  Google Scholar 

  22. Smeenk RM, Verwaal VJ, Zoetmulder FA (2006) Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei—a report of 103 procedures. Eur J Surg Oncol 32:186–190

    Article  CAS  PubMed  Google Scholar 

  23. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J et al (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6:790–796

    Article  CAS  PubMed  Google Scholar 

  24. Yan TD, Black D, Savady R, Sugarbaker PH (2006) Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 24:4011–4019

    Article  PubMed  Google Scholar 

  25. Elias D, Blot F, El OA, Antoun S, Lasser P et al (2001) Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71–76

    Article  CAS  PubMed  Google Scholar 

  26. Glehen O, Mohamed F, Sugarbaker PH (2004) Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 240:278–285

    Article  PubMed  Google Scholar 

Download references

Declaration of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of General, Visceral, Vascular and Thoracic Surgery, University Medicine Berlin, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany

    Wieland Raue, Maik Kilian, Chris Braumann, Vladimir Atanassow, Anna Makareinis, Sonja Caldenas & Jens Hartmann

  2. Department of General and Visceral Surgery, Asklepios Klinik Altona, Paul-Ehrlich-Str. 1, 22763, Hamburg, Germany

    Wolfgang Schwenk

Authors
  1. Wieland Raue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maik Kilian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chris Braumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vladimir Atanassow
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna Makareinis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sonja Caldenas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wolfgang Schwenk
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jens Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wieland Raue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raue, W., Kilian, M., Braumann, C. et al. Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model. Int J Colorectal Dis 25, 245–250 (2010). https://doi.org/10.1007/s00384-009-0819-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-009-0819-7

Keywords

Search

Navigation